Pulmonx Corp - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
LUNG Nasdaq 3841 https://pulmonx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Pulmonx Corp

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 - Apr 10th, 2024 8:05 pm
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer - Apr 2nd, 2024 8:05 pm
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Mar 15th, 2024 9:00 pm
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp - Mar 1st, 2024 4:35 am
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial - Feb 26th, 2024 1:00 pm
US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results - Feb 24th, 2024 1:04 pm
Pulmonx Full Year 2023 Earnings: Beats Expectations - Feb 23rd, 2024 11:20 am
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript - Feb 22nd, 2024 2:55 pm
Q4 2023 Pulmonx Corp Earnings Call - Feb 22nd, 2024 11:56 am
Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses - Feb 21st, 2024 9:44 pm
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results - Feb 21st, 2024 9:06 pm
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer - Feb 21st, 2024 9:05 pm
Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) - Feb 17th, 2024 5:08 am
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 - Feb 7th, 2024 9:05 pm
Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG) - Dec 23rd, 2023 4:19 am
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors - Dec 11th, 2023 2:00 pm
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare - Nov 17th, 2023 6:08 pm
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference - Nov 15th, 2023 9:05 pm
Pulmonx to Participate at Upcoming Investor Conferences - Oct 31st, 2023 8:05 pm
Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript - Oct 31st, 2023 1:00 pm